Efficacy and Safety of Fluticasone Furoate and Oxymetazoline Nasal Spray: A Novel First Fixed Dose Combination for the Management of Allergic Rhinitis with Nasal Congestion
RS Kumar,Manish Kumar Jain,Jitendra Singh Kushwaha,Santosh Patil,Vasanti Patil,Soumya Ghatak,Jayesh Sanmukhani,Ravindra Mittal
DOI: https://doi.org/10.2147/JAA.S357288
2022-06-11
Journal of Asthma and Allergy
Abstract:RS Kumar, 1 Manish Kumar Jain, 2 Jitendra Singh Kushwaha, 3 Santosh Patil, 4 Vasanti Patil, 5 Soumya Ghatak, 6 Jayesh Sanmukhani, 7 Ravindra Mittal 7 1 Department of Pulmonary Medicine, Government Medical College & Government General Hospital, Srikakulam, India; 2 Department of Pulmonary Medicine, Maharaja Agrasen Superspeciality Hospital, Jaipur, India; 3 Department of Medicine, Prakhar Hospital Pvt. Ltd, Kanpur, India; 4 Department of ENT, Jeevan Rekha Hospital, Belgavi, India; 5 Department of ENT, Rajarshi Chhatrapati Shahu Maharaj Government Medical College and CPR Hospital, Kolhapur, India; 6 Department of ENT, College of Medicine and Sagore Dutta Hospital, Kolkata, India; 7 Department of Clinical Research and Regulatory Affairs, Cadila Healthcare Limited, Ahmedabad, India Correspondence: Jayesh Sanmukhani, Department of Clinical Research and Regulatory Affairs, Cadila Healthcare Ltd, Ahmedabad, India, Tel +91 76000 12192, Email ; Objective: To compare the efficacy and safety of a fixed dose combination of Fluticasone Furoate and Oxymetazoline Hydrochloride Nasal Spray 27.5/50 mcg (FDC) with Fluticasone Furoate Nasal Spray 27.5 mcg (Fluticasone) in the management of allergic rhinitis. Patients and Methods: A prospective, randomized, double-blind, two-arm, active-controlled, parallel, multicenter, comparative clinical study was conducted in patients with allergic rhinitis aged 18 years and above having moderate-to-severe nasal congestion. Results: A total of 250 patients were randomized (1:1) to receive either the FDC or Fluticasone alone in a dose of two sprays in each nostril once daily at night. There was a significantly ( P 0.05). Conclusion: The FDC was superior to Fluticasone alone in relieving the nasal congestion and reduction of Total Nasal Symptom Score in allergic rhinitis patients with moderate-to-severe nasal congestion when administered once daily in the evening. Oxymetazoline when used along with the nasal steroid in a once daily dose does not cause rebound congestion and rhinitis medicamentosa even after long-term continuous use of 28 days. Keywords: Fluticasone Furoate, oxymetazoline, nasal spray, allergic rhinitis, nasal congestion Allergic rhinitis is a common inflammatory disease condition of the upper respiratory tract. The disease is quite prevalent across the world, with reports ranging from 10–40% in various age groups in the western world including the United States and 10–13% in India (Delhi state of North India). 1,2 Moreover, its symptoms are often associated with asthmatic children (up to 75%) and adults (up to 80%). The disease has a great impact on various aspects of patient's quality-of-life (physical, social, and psychological). 3,4 It is currently being managed by various non-pharmacological (steam inhalation, etc.) and pharmacological (oral and intranasal) modalities, however, intranasal steroids are considered to be the first line of management for both the nasal and ocular symptoms 5 and are preferred over oral H1-antihistamines and leukotriene receptor antagonists and intranasal H1-antihistamines. Fluticasone Furoate is an intranasal glucocorticoid with enhanced receptor affinity, potent and long anti-inflammatory activity and low systemic bioavailability in comparison to other glucocorticoids currently in usage. It is one of the most commonly used intranasal steroids for the treatment of allergic rhinitis. 4 Fluticasone Furoate nasal spray (27.5 mcg per spray) is already approved for the treatment of symptoms of allergic rhinitis in various countries. Although intranasal steroids are the first line of treatment, only about 60% of subjects achieve excellent relief with the same in the clinical studies. Also the effect of intranasal steroids takes a few days to reach maximum efficacy (even though the effect starts after 12 hours), thereby suggesting the need for improved treatment mod -Abstract Truncated-
immunology,allergy,respiratory system